Drug Type Small molecule drug |
Synonyms GMI-2093 |
Target |
Action inhibitors |
Mechanism galectin-3 inhibitors(Galectin-3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fibrosis | Preclinical | United States | - | |
| Neoplasms | Preclinical | United States | - |





